Dermata Therapeutics(DRMA) - 2021 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 Commission File Number: 001-40739 | --- | |---------------------------------| | | | | | Delaware | | | | (State or other jurisdiction of | | incorporation or organization) | DERMATA THERAPEUTICS, INC. (Exact name of registrant as specified in the charter) 82-1510982 (I.R.S. Employer Identifi ...